Asterias Biotherapeutics, Inc. Operating Cash Flow
Asterias Biotherapeutics, Inc. reported Operating Cash Flow of -$10.04 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2018-11-09
- Asterias Biotherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-09-30 was -$2.91M.
- Asterias Biotherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-06-30 was -$3.19M.
- Asterias Biotherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-03-31 was -$3.94M.
- Asterias Biotherapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2017-12-31 was -$5.79M.
- Asterias Biotherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$24.44M.
- Asterias Biotherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2016 was -$19.01M.
- Asterias Biotherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2015 was -$12.39M.
- Asterias Biotherapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2013 was -$1.33M.
| Period end | Net Cash Provided by (Used in) Operating Activities 0 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 15 month | Net Cash Provided by (Used in) Operating Activities 18 month | Net Cash Provided by (Used in) Operating Activities 21 month | Net Cash Provided by (Used in) Operating Activities 24 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | -$2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$6.10M derived: sum of 2 quarters · filed 2018-11-09 | -$10.04M 10-Q · filed 2018-11-09 | -$15.82M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2018-06-30 | -$3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$7.13M 10-Q · filed 2018-08-09 | -$12.91M derived: sum of 3 quarters · filed 2018-08-09 | -$17.44M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2018-03-31 | -$3.94M 10-Q · filed 2018-05-09 | -$9.72M derived: sum of 2 quarters · filed 2018-05-09 | -$14.24M derived: sum of 3 quarters · filed 2018-11-09 | -$21.22M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-12-31 | -$5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$10.31M derived: sum of 2 quarters · filed 2018-11-09 | -$17.28M derived: sum of 3 quarters · filed 2018-11-09 | -$24.44M 10-K · filed 2018-03-15 | ||||||
| 2017-09-30 | -$4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$11.50M derived: sum of 2 quarters · filed 2018-11-09 | -$18.65M 10-Q · filed 2018-11-09 | -$22.59M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-06-30 | -$6.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$14.13M 10-Q · filed 2018-08-09 | -$18.06M derived: sum of 3 quarters · filed 2018-08-09 | -$23.12M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2017-03-31 | -$7.15M 10-Q · filed 2018-05-09 | -$11.09M derived: sum of 2 quarters · filed 2018-05-09 | -$16.15M derived: sum of 3 quarters · filed 2018-05-09 | |||||||
| 2016-12-31 | -$3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$8.99M derived: sum of 2 quarters · filed 2018-03-15 | -$19.01M 10-K · filed 2018-03-15 | |||||||
| 2016-09-30 | -$5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$15.07M 10-Q · filed 2017-11-14 | ||||||||
| 2016-06-30 | -$10.01M 10-Q · filed 2017-08-14 | |||||||||
| 2015-12-31 | -$12.39M 10-K · filed 2018-03-15 | |||||||||
| 2014-09-30 | -$7.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$8.32M derived: sum of 2 quarters · filed 2014-11-10 | -$9.77M 10-Q · filed 2014-11-10 | -$12.81M derived: sum of 4 quarters · filed 2014-11-10 | -$11.09M 10-Q · filed 2014-11-10 | |||||
| 2014-06-30 | -$485.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$1.93M 10-Q · filed 2014-08-11 | -$4.98M derived: sum of 3 quarters · filed 2014-08-11 | -$3.95M derived: sum of 4 quarters · filed 2014-11-10 | -$3.26M 10-Q · filed 2014-08-11 | |||||
| 2014-03-31 | -$1.45M 10-Q · filed 2014-05-12 | -$4.50M derived: sum of 2 quarters · filed 2014-05-12 | -$3.47M derived: sum of 3 quarters · filed 2014-11-10 | -$2.83M derived: sum of 4 quarters · filed 2014-11-10 | -$2.78M 10-Q · filed 2014-05-12 | |||||
| 2013-12-31 | -$3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$2.02M derived: sum of 2 quarters · filed 2014-11-10 | -$1.38M derived: sum of 3 quarters · filed 2014-11-10 | -$1.33M 10-K · filed 2014-03-17 | -$1.33M 10-K · filed 2014-03-17 | |||||
| 2013-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.66M derived: sum of 2 quarters · filed 2014-11-10 | $1.72M 10-Q · filed 2014-11-10 | -$3.91M 10-Q · filed 2013-11-12 | -$4.67M 10-Q · filed 2013-11-12 | |||||
| 2013-06-30 | $638.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $693.20K 10-Q · filed 2014-08-11 | $693.20K derived: sum of 3 quarters · filed 2014-08-11 | |||||||
| 2013-03-31 | $54.42K 10-Q · filed 2014-05-12 | $54.42K derived: sum of 2 quarters · filed 2014-05-12 | ||||||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 | |||||||||
| 2012-09-30 | -$32.31K 10-Q · filed 2013-11-12 |